RANDOMIZED CONTROLLED TRIAL OF LATE IN-HOSPITAL ANGIOGRAPHY AND ANGIOPLASTY VERSUS CONSERVATIVE MANAGEMENT AFTER TREATMENT WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION

被引:92
作者
BARBASH, GI
ROTH, A
HOD, H
MODAN, M
MILLER, HI
RATH, S
ZAHAV, YH
KEREN, G
MOTRO, M
SHACHAR, A
BASAN, S
AGRANAT, O
RABINOWITZ, B
LANIADO, S
KAPLINSKY, E
机构
[1] TEL AVIV MED CTR & SCH MED, TEL AVIV, ISRAEL
[2] TEL AVIV UNIV, SACKLER SCH MED, DEPT EPIDEMIOL & BIOSTAT, TEL AVIV, ISRAEL
关键词
D O I
10.1016/0002-9149(90)90478-J
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although both the European Cooperative Study Group and the Thrombolysis in Myocardial Infarction MB trial indicated that angiography and angioplasty as routine measures after thrombolytic treatment do not improve clinical outcome in patients with acute myocardial infarction, the potential benefit of angioplasty may have been negated by the fact that the procedure was performed too soon (<32 hours) after admission. A similar study was designed in which delayed invasive treatment was compared with conservative treatment in 201 patients with acute myocardial infarction given recombinant tissue-type plasminogen activator. The 97 patients randomized to the invasive group underwent routine coronary angiography and angioplasty 5 ± 2 days after thrombolytic therapy, whereas the 104 patients randomized to the conservative group underwent angiography only for recurrent postinfarction angina or exercise-induced ischemia. Baseline characteristics of both groups were similar. In the invasive group, 92 patients underwent angiography, 49 angioplasty and 11 coronary artery bypass surgery. In the conservative group, 40 patients experienced early ischemia, 39 underwent angiography, 20 angioplasty and 4 coronary artery bypass surgery. Reinfarction rate and preservation of left ventricular function at discharge or 8 weeks after discharge did not differ in the 2 groups. Total mortality after a mean followup of 10 months was 8 of 97 in the invasive and 4 of 104 in the conservative groups (p = 0.15). However, if only patients who died after the timing of the scheduled protocol catheterization in the invasive arm were included, mortality was 5 of 94 and 0 of 100 in the invasive and conservative treatment groups, respectively (p = 0.02). A significantly higher rate of rehospitalization was observed among patients assigned to the conservative group and in both groups, and a history of angina pectoris was significantly associated with more rehospitalizations. Results of this study indicate that conservative treatment is preferable to invasive treatment, even when cardiac catheterization is delayed. © 1990.
引用
收藏
页码:538 / 545
页数:8
相关论文
共 12 条
[1]  
[Anonymous], 1989, NEW ENGL J MED, V320, P618
[2]   ANTECEDENT ANGINA - A PREDICTOR OF RESIDUAL STENOSIS AFTER THROMBOLYTIC THERAPY [J].
BERGELSON, BA ;
RUOCCO, NA ;
RYAN, TJ ;
HANKIN, BR ;
JACOBS, AK ;
FAXON, DP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 14 (01) :91-95
[3]   THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) TRIAL, PHASE-I - A COMPARISON BETWEEN INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR AND INTRAVENOUS STREPTOKINASE - CLINICAL FINDINGS THROUGH HOSPITAL DISCHARGE [J].
CHESEBRO, JH ;
KNATTERUD, G ;
ROBERTS, R ;
BORER, J ;
COHEN, LS ;
DALEN, J ;
DODGE, HT ;
FRANCIS, CK ;
HILLIS, D ;
LUDBROOK, P ;
MARKIS, JE ;
MUELLER, H ;
PASSAMANI, ER ;
POWERS, ER ;
RAO, AK ;
ROBERTSON, T ;
ROSS, A ;
RYAN, TJ ;
SOBEL, BE ;
WILLERSON, J ;
WILLIAMS, DO ;
ZARET, BL ;
BRAUNWALD, E .
CIRCULATION, 1987, 76 (01) :142-154
[4]   A RANDOMIZED TRIAL OF INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR FOR ACUTE MYOCARDIAL-INFARCTION WITH SUBSEQUENT RANDOMIZATION TO ELECTIVE CORONARY ANGIOPLASTY [J].
GUERCI, AD ;
GERSTENBLITH, G ;
BRINKER, JA ;
CHANDRA, NC ;
GOTTLIEB, SO ;
BAHR, RD ;
WEISS, JL ;
SHAPIRO, EP ;
FLAHERTY, JT ;
BUSH, DE ;
CHEW, PH ;
GOTTLIEB, SH ;
HALPERIN, HR ;
OUYANG, P ;
WALFORD, GD ;
BELL, WR ;
FATTERPAKER, AK ;
LLEWELLYN, M ;
TOPOL, EJ ;
HALEY, B ;
SIU, CO ;
BECKER, LC ;
WEISFELDT, ML .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (26) :1613-1618
[5]  
KNATTERUD G, 1988, JAMA-J AM MED ASSOC, V260, P2849
[6]   PERCUTANEOUS TRANS-LUMINAL CORONARY ANGIOPLASTY IMMEDIATELY AFTER INTRA-CORONARY STREPTOLYSIS OF TRANSMURAL MYOCARDIAL-INFARCTION [J].
MEYER, J ;
MERX, W ;
SCHMITZ, H ;
ERBEL, R ;
KIESSLICH, T ;
DORR, R ;
LAMBERTZ, H ;
BETHGE, C ;
KREBS, W ;
BARDOS, P ;
MINALE, C ;
MESSMER, BJ ;
EFFERT, S .
CIRCULATION, 1982, 66 (05) :905-913
[7]  
PASSAMANI E, 1985, NEW ENGL J MED, V312, P932
[8]   PROGNOSTIC-SIGNIFICANCE OF ANGINA-PECTORIS BEFORE 1ST ACUTE MYOCARDIAL-INFARCTION [J].
PIERARD, LA ;
DUBOIS, C ;
SMEETS, JP ;
BOLAND, J ;
CARLIER, J ;
KULBERTUS, HE .
AMERICAN JOURNAL OF CARDIOLOGY, 1988, 61 (13) :984-987
[9]  
SIMOONS ML, 1988, LANCET, V1, P199
[10]   A RANDOMIZED TRIAL OF IMMEDIATE VERSUS DELAYED ELECTIVE ANGIOPLASTY AFTER INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION [J].
TOPOL, EJ ;
CALIFF, RM ;
GEORGE, BS ;
KEREIAKES, DJ ;
ABBOTTSMITH, CW ;
CANDELA, RJ ;
LEE, KL ;
PITT, B ;
STACK, RS ;
ONEILL, WW .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (10) :581-588